Chloride imbalance in preterm babies
Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at chloride levels in preterm babies admitted to the neonatal intensive care unit (NICU) within their first day of life. It aims to understand chloride imbalance and how it might affect their health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Babies born before 32 weeks of pregnancy or weighing less than 1500 grams
- Admitted to the NICU within the first 24 hours after birth
- No major birth defects
- No genetic or chromosomal conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a careful CPAP breathing support plan helps very premature babies breathe better. It may be an option for babies who are stable on low oxygen settings and have few breathing pauses.
This study looks at babies born very early who have severe lung disease (grade 3 BPD) and still need a breathing machine. Researchers will use tests to understand their lung problems better, which may help guide their care.
This trial compares giving less fluid versus the usual amount to very early preterm babies to see if it helps prevent bronchopulmonary dysplasia, a chronic lung condition. The goal is to find the safest way to manage fluids and protect their developing lungs.
This study looks at children born very early who have chronic lung disease (BPD) and get a lung infection. Doctors want to learn more about how these infections affect breathing and health over time.
This study looks at medical information from premature babies to find early signs of a lung condition called bronchopulmonary dysplasia (BPD), which can affect breathing. The goal is to help doctors predict and manage this condition better.
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
Hear when a new Bronchopulmonary Dysplasia (BPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.